By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Collegium Pharmaceutical, Inc. 

400 Highland Corporate Drive

Cumberland  Rhode Island  02864  U.S.A.
Phone: 401-762-2000 Fax: 401-762-2043



Company News
Collegium (COLL) Announces Closing Of Its IPO And Exercise In Full Of Option To Purchase Additional Shares 5/13/2015 7:38:10 AM
Collegium Announces Pricing Of Its IPO 5/7/2015 7:39:47 AM
Collegium To Present Xtampza ER Pivotal Phase III Data At The 2015 American Academy Of Pain Medicine Annual Meeting 3/17/2015 7:22:18 AM
Collegium Scores $50 Million to Advance Abuse-Deterrent Opioid 3/10/2015 6:16:03 AM
Collegium Pharmaceutical, Inc. Announces Notice Of Allowance For U.S. Patent Covering Deterx, An Abuse-Deterrent, Extended-Release, Technology Platform 2/26/2015 7:59:11 AM
Collegium Pharmaceutical, Inc. Secures FDA Acceptance For Filing Of NDA For XTAMPZA ER (Oxycodone Extended-Release Capsules), An Abuse-Deterrent Analgesic For Chronic Pain 2/17/2015 7:30:39 AM
Collegium Pharmaceutical, Inc. Submits New Drug Application For Xtampza™ ER (Oxycodone Extended-Release); Its Abuse-Deterrent, Extended-Release Analgesic For The Treatment Of Chronic Pain 12/15/2014 9:26:19 AM
Collegium Pharmaceutical, Inc. Announces Publication Of Abuse-Deterrent Data On Oxycodone Deterx® In Journal Of Opioid Management 8/20/2014 10:00:52 AM
Collegium Pharmaceutical, Inc. Awarded Grant From National Institutes of Health (NIH) To Advance Development Of Oxymorphone Deterx®, An Abuse-Deterrent, Extended-Release Product For Chronic Pain 8/7/2014 2:07:30 PM
Collegium Pharmaceutical, Inc. Announces Positive Top-Line Data From Phase III Study of Oxycodone DETERx®, Its Abuse-Deterrent, Extended-Release Product For Chronic Pain 8/7/2014 11:22:02 AM